Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences, Inc. (RNA) Interest Expenses (2019 - 2020)

Avidity Biosciences' Interest Expenses history spans 2 years, with the latest figure at $131000.0 for Q2 2020.

  • For Q2 2020, Interest Expenses fell 89.22% year-over-year to $131000.0; the TTM value through Mar 2021 reached $131000.0, down 98.15%, while the annual FY2020 figure was $209000.0, 97.17% down from the prior year.
  • Interest Expenses reached $131000.0 in Q2 2020 per RNA's latest filing, up from $78000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $4.3 million in Q4 2019 to a low of $78000.0 in Q1 2020.